Actinium Pharmaceuticals Inc. (ATNM)
NYSE · Healthcare
Actinium Pharmaceuticals Inc. Total Liabilities 2010–2025
Actinium Pharmaceuticals Inc. annual/quarterly total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Actinium Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 43.9M, a 2.50% decrease year-over-year.
- Actinium Pharmaceuticals Inc. total liabilities for 2025 were 43.9M, a 2.50% decrease from 2023.
- Actinium Pharmaceuticals Inc. total liabilities for 2023 were 45.1M, a 5.54% decrease from 2022.
- Actinium Pharmaceuticals Inc. total liabilities for 2022 were 47.7M, a 597.22% increase from 2021.
- Actinium Pharmaceuticals Inc. total liabilities for 2021 were 6.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Actinium Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $44 |
| 2023 | $45 |
| 2022 | $48 |
| 2021 | $7 |
| 2011 | $0 |
| 2010 | $0 |
| Actinium Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $44 |
| 2023-12-31 | $45 |
| 2022-12-31 | $48 |
| 2021-12-31 | $7 |
| 2011-12-31 | $0 |
| 2010-12-31 | $0 |
Actinium Pharmaceuticals Inc. Total Liabilities — FAQ
Actinium Pharmaceuticals Inc. (ATNM) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATNM's total liabilities history?
The chart and table above show Actinium Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.